HydGene Renewables backed for hydrogen from biomass

The Clean Energy Finance Corporation (CEFC) has backed HydGene Renewables which has developed an alternative green hydrogen solution that turns biomass into hydrogen in a process that is both renewable and carbon negative. The HydGene technique uses novel biocatalysts to convert the sugars derived from organic waste, including agricultural waste, into valuable products like hydrogen.…

Sicona raises $22 million for battery expansion

Sicona Battery Technologies has raised $22 million in Series A funding which will be used to further the company’s development plans both in Australia and the United States. The $22 million investment was led by India’s Himadri Speciality Chemical Ltd, Australian venture capital investor Artesian, and Electrification & Decarbonization AIE LP, a fund managed by…

Serco tunes up Oboe for landing craft need

The Australian Maritime Alliance (AMA) has reviewed all aspects of its proposal to meet the Australian Defence Force’s needs for medium duty landing craft to ensure the group remained ready to deliver the critical programme for Australia. The AMA, made up of engineering group and shipbuilder Civmec, and defence services company Serco, looked at AMA’s…

MASSLAM manufacturing expansion underway

Australian Sustainable Hardwoods (ASH) has announced it is doubling production capacity of its MASSLAM glue-laminated (GLT) mass-timber column and beam system. The family-owned company’s Heyfield, Victoria plant (pictured, below) is being expanded and new equipment added to boost throughput. MASSLAM is designed and manufactured for assembly on site for domestic and large commercial buildings. ASH…

Vaxxas opens new Brisbane manufacturing facility

Biotechnology company Vaxxas in partnership with the Queensland Government, has announced the opening of its global headquarters and state-of-the-art manufacturing facility in Brisbane. The company, which is commercialising a needle-free vaccine patch platform, has opened its custom-built 5,500m² Vaxxas Biomedical Facility to support the scale-up of Vaxxas’ needle-free vaccine technology platform. The company’s high-density microarray…